Primary hypogonadism: why some restart advice misses the biology
Why stimulating LH cannot be assumed to reverse testicular failure, and how testosterone replacement, symptom relief and fertility care differ.
Read articleFor informational and research purposes only.
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Find a topic you’re curious about and take a closer look.
Why stimulating LH cannot be assumed to reverse testicular failure, and how testosterone replacement, symptom relief and fertility care differ.
Read articleCompare a complete year of testosterone care, including medicine, monitoring, coverage, supplies, and the time each formulation requires.
Read articleWhat product testing, absorption research, and prescribing guidance can tell you about a custom testosterone cream—and what they cannot establish.
Read articleCell counts, surface proteins and thymic-output markers can reveal biological activity. Learn why clinical outcomes still need their own evidence.
Read articleRetatrutide sharply reduced MRI-measured liver fat in a small substudy. That result differs from proving MASH resolution, fibrosis improvement or fewer liver complications.
Read articleBPC-157 changes vessel behavior in laboratory studies. Learn why that raises specific research questions without settling long-term human cancer safety.
Read articleHumanin can support cell survival, but experimental tumor studies show why that effect needs cancer-specific scrutiny.
Read articleFeline exenatide studies show how species, disease stage, background care and measured outcomes determine what pet peptide research can actually tell owners.
Read articleHuman studies show that kisspeptin can stimulate LH and testosterone. The clinical question is whether those signals lead to sustained, meaningful benefits.
Read articleOlder hepatitis studies tested specific viral and liver outcomes. Understand delayed responses, mixed results and the relevance to today's antiviral care.
Read articleD2 and D3 both raise vitamin D status, but not always equally. Understand fractional blood results, direct comparisons and the limits of clinical claims.
Read articlePellets reduce routine administration, but a long-lasting depot is harder to adjust. Product differences, monitoring and a clear response plan belong in the decision.
Read article362–373 of 600 articles